Cagrilintide With Semaglutide: A Way to Prevent Diabesity?

CagriSema (cagrilintide plus semaglutide) led to weight loss 'of a magnitude not previously reported with pharmacotherapies in type 2 diabetes,' plus improved CGM measures, in a phase 2 trial.

Related Keywords

Denmark ,Boston ,Massachusetts ,United States ,California ,Belgium ,Danish ,American ,Juanp Frias ,Los Angeles ,Katholieke Universiteit Leuven ,Mariee Mcdonnell ,Carolinem Apovian ,Chantal Mathieu ,Novo Nordisk ,Velocity Clinical Research ,Harvard Medical School ,American Diabetes Association ,Scientific Sessions ,Elisabetta Patorno ,Medscape Medical ,Synergistic Effect ,Both Glycemic Control ,Weight Los ,